UCL launches landmark trial of Alzheimer’s blood test
A major UCL-led clinical trial, aiming to transform the diagnosis of Alzheimer’s disease through a simple blood test,…
Study identifies C1orf122 as prognostic marker in liver cancer
Primary liver cancer is the third leading cause of cancer-related deaths, of which hepatocellular carcinoma (HCC) accounts for…
SLIT2 protein levels in the eye and blood linked to cognitive function
Neurocognitive impairments are classified by pathological changes with potential for destruction of neural tissue. One change known to…
Blood-based biomarkers reveal barriers to diversity in Alzheimer’s disease trials
Some of the populations with the highest risk for Alzheimer’s disease remain greatly underrepresented in clinical trials-and a…
NYU Langone strengthens world-leading GI cancer program with renowned leaders
NYU Langone Health’s Perlmutter Cancer Center announces the arrival of acclaimed cancer leaders Anirban Maitra, MD, and Manuel…
Omega-3 supplements lower heart rate in male athletes
EPA- and DHA-rich oils boosted athletes’ omega-3 index and eased exercise strain, but the supplements offered no extra…
CHI3L1 emerges as a powerful biomarker for liver disease diagnosis and management
The identification of Chitinase-3-like protein 1 (CHI3L1) as a crucial biomarker in liver disease is revolutionizing how clinicians…